
|Videos|October 22, 2021
Dr. Mills weighs in on the benefits of testosterone enanthate
Author(s)Urology Times staff
“There's 3 different levels of dosing…so this does provide you with a mechanism for titration if you're going to be using that in your patients,” says Jesse N. Mills, MD.
Advertisement
In this video, Jesse N. Mills, MD, discusses the important findings from the study, “Subcutaneous Testosterone Enanthate and the Effect of Body Mass Index on Serum Testosterone in Men with Testosterone Deficiency,” presented recently at the 2021 Sexual Medicine Society of North America Fall Scientific Meeting. Mills is an associate clinical professor of urology at the David Geffen School of Medicine, the director of the UCLA division of Andrology, the director of the Men’s Clinic and the chief of UCLA Santa Monica Urology, University of California, Los Angeles
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
2
FDA grants tentative approval to generic olaparib tablets across previously approved indications
3
Experts discuss the challenge of detecting CIS in bladder cancer
4
Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC
5












